Position in GH
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$171,184
+$65,790 QoQ
Shares Held
1,141
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#458
of 594 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $400,845 across 10 Diagnostics & Research names. GH ranks #1 (42.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
1,141 | $171,184 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
185 | $92,751 | |
| 3 | A |
Agilent Technologies, Inc.
|
608 | $80,760 | |
| 4 | DHR |
Danaher Corp /De/
|
109 | $20,762 | |
| 5 | WAT |
Waters Corp /De/
|
35 | $13,126 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
23 | $12,180 | |
| 7 | DGX |
Quest Diagnostics Inc
|
26 | $5,510 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
5 | $2,632 |
All Filings in GH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,184 | 1,141 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $105,394 | 1,141 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $116,541 | 1,141 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $71,289 | 1,141 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $59,377 | 1,141 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $48,606 | 1,141 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $34,857 | 1,141 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $26,174 | 1,141 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||